Fact CheckerSign in

NCT07811219Not yet recruiting

RESP-FIT: A Respiratory Muscle Strength Training Intervention for COPD

Source: ClinicalTrials.gov · Last updated 8 Oct 2026

Brief summary (registry, in English)

Individuals with chronic obstructive pulmonary disease (COPD) often experience dyspnea, low physical activity, and reduced quality of life. RESP-FIT is a randomized controlled trial evaluating a remotely delivered respiratory muscle strength training intervention combined with mobile health tools to improve dyspnea, respiratory muscle strength, and physical activity in adults with COPD.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
288 (estimated)
First submitted
21 Aug 2026
Start date
15 Oct 2026
Primary completion date
15 Apr 2030
Lead sponsor
Medical University of South Carolina
Diseases
COPD
NCT number
NCT07811219

What you commit to

  • Study type: Interventional
  • Planned participants: 288
  • From 15 Oct 2026 to the primary completion date, 15 Apr 2030
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Concurrent enrollment in conflicting COPD or behavioral intervention trials

Other illness

  • Cognitive impairment preventing participation
  • Other significant respiratory disease

Other

  • Active substance abuse
  • Non-English speaking

Who the study is looking for

  • Age ≥40 years
  • Clinical diagnosis of COPD
  • Ability to provide informed consent
  • Willingness to use mobile health devices and apps
  • Access to Wi-Fi and mailing address in the U.S.

Age in the registry: 40 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.